PHARMAC have announced CGM funding for people with Type 1 diabetes from 1 October 2024. More detail to come.Additional information on Diabetes New Zealand website and the Pharmac Websites
You have nothing in your cart.
If you know the product code enter it here
If you know the product code enter it into the search field
Recombinant Human TIM-3-Fc Chimera (carrier-free), 10 μg
Recombinant Human TIM-3-Fc Chimera (carrier-free), 25 μg
Recombinant Human TIMP-1 (carrier-free), 10 μg
Recombinant Human TIMP-1 (carrier-free), 100 μg
Recombinant Human TIMP-1 (carrier-free), 25 μg
Recombinant Human TIMP-2 (carrier-free), 100 μg
Recombinant Human TIMP-2 (carrier-free), 25 μg
Recombinant Human TNFRSF11B (carrier-free), 10 µg
Recombinant Human TNFRSF11B (carrier-free), 100 µg
Recombinant Human TNFRSF11B (carrier-free), 25 µg
Recombinant Human TNFRSF11B (carrier-free), 500 µg
Recombinant Human TNFSF18 (GITRL) (carrier-free), 10 µg
Recombinant Human TNFSF18 (GITRL) (carrier-free), 100 µg
Recombinant Human TNFSF18 (GITRL) (carrier-free), 25 µg
Recombinant Human TNFSF9 (4-1BBL) (carrier-free), 10 µg
Recombinant Human TNFSF9 (4-1BBL) (carrier-free), 100 µg